We aimed to retrospectively analyze morbidity and mortality in recipients of kidney transplant receiving immunosuppressive therapy. Overall, 228 patients who underwent kidney and liver transplantation were included in the study. The overall graft survival of patients who underwent kidney and liver transplantation from 1999 to 2017 was 84.2%. Combinations including cyclosporine, were associated with high rate of complications acute rejection, CMV and candida infections as compared to tacrolimus. The most unfavorable in terms of mortality was combination of cyclosporine – mycophenol mofetil.
Stent thrombosis (ST) is a known severe complication following percutaneous coronary intervention (PCI). We present two rare cases of very late stent thrombosis (VLST) occurring beyond ten years post initial drug eluting stent (DES) deployment, which has not previously been documented. Additionally, one patient experienced recurrent episodes of VLST within the same vessel. The cases demonstrate different contributing factors for VLST development.